Tesamorelin (20mg)
Description
A single-component research material supplied for controlled research environments. Tesamorelin (20 mg) is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus, widely used in research exploring GHRH receptor signaling, somatotroph axis regulation, and pulsatile growth hormone secretion dynamics in model systems.
Composition
-
Tesamorelin (modified GHRH(1-44) analog): 20 mg
-
Appearance: lyophilized powder in a sealed research vial
Research Focus (non-clinical)
-
Investigation of GHRH receptor binding kinetics and downstream somatotroph signaling cascades in cell culture studies
-
Evaluation of pulsatile growth hormone release patterns and IGF-1 axis modulation in in vitro and in vivo experimental models
-
Assessment of lipid metabolism biomarkers and visceral adipose tissue regulation under controlled laboratory conditions
-
Stability and bioactivity characterization of lyophilized Tesamorelin under laboratory storage conditions
Documentation
-
Lot-specific COA available
-
Batch and lot traceability
Important Notice
-
For research use only
-
Not for human consumption
-
Not intended to diagnose, treat, cure, or prevent any disease
Quality & Manufacturing
-
Lot-specific COA
-
Lyophilized for transit stability; batch traceable
-
Tamper-evident seal; lot & test date on each vial
-
No MOQ for online orders
-
Bulk orders for physical locations start at 25-unit minimum

